| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |